PVCT president granted Series D-1 preferred shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PROVECTUS BIOPHARMACEUTICALS, INC. reported that President and director Dominic Rodrigues received a grant of 45,860 shares of Series D-1 Convertible Preferred Stock at a price of $0.00 per share. Each preferred share is convertible into 10 shares of common stock, representing 458,600 underlying common shares. After this grant, Rodrigues holds 1,383,736 shares of Series D-1 Preferred Stock, which will automatically convert into common stock on December 31, 2028 unless converted earlier under the series’ terms.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Series D-1 Convertible Preferred Stock | 45,860 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each share of Series D-1 Preferred Stock is convertible into 10 shares of the Issuer's common stock, par value $0.001 per share ("Common Stock").
- F2. The Series D-1 Convertible Preferred Stock will automatically convert into Common Stock on December 31, 2028, unless earlier converted into Common Stock in accordance with the terms of the Certificate of Designation for the Series D-1 Convertible Preferred Stock.
Key Figures
Key Terms
Series D-1 Convertible Preferred Stock financial
convertible financial
automatic convert financial
Certificate of Designation regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did PVCT report for Dominic Rodrigues on this Form 4?
What are Dominic Rodrigues’ Series D-1 preferred holdings after this PVCT transaction?
When will the PVCT Series D-1 Convertible Preferred Stock automatically convert?
Did this PVCT Form 4 show any open-market buys or sells of common stock?
AI-generated analysis. How Rhea-AI works. Not financial advice.